Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is engaged in manufacturing of pharmaceutical products. It offers anti-biotic, gynecological , gastroenterological, anti-allergic, anti-fungal, , pediatrics, orthopedics etc.
Lark Laboratories (India) Ltd, is an unlisted public company incorporated on 11 April, 1979. It is classified as a public limited company and is located in , Delhi. It's authorized share capital is INR 5.00 cr and the total paid-up capital is INR 4.26 cr.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Badri Bishal Tikmani
Shareholder
|
00312723 | 46 years |
| Director | Kantilal Vajeraj Jain
Shareholder
|
00316736 | 44 years |
| Director | Kamal Prabha Anand
Shareholder
|
00316795 | 24 years |
| Whole-time Director | Vijay Kumar Gupta
Shareholder
|
00316707 | 47 years |
| Managing Director | Aprajita Takiar
Shareholder
|
00310490 | 27 years |
| Director | Vijay Kumar Uppal
Shareholder
|
00073325 | 47 years |
| Director | Virender Uppal
Shareholder
|
00073331 | 47 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Small Industries Development Bank of India
No. of Loans: 13
Total Amount : 13.9 cr
Kotak Mahindra Bank Limited
No. of Loans: 2
Total Amount : 11.6 cr
HDFC Bank Limited
No. of Loans: 4
Total Amount : 0.9 cr
Syndicate Bank
No. of Loans: 10
Total Amount : 0.9 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| SPINZER PHARMACEUTICALS PRIVATE LIMITED | Delhi | 1983 | ₹ 1.0 L |
Read more
The incorporation date of LARK LABORATORIES (INDIA) LTD is 11 April, 1979
The authorized share capital of LARK LABORATORIES (INDIA) LTD is INR ₹ 5.0 Cr.
The paid-up capital of LARK LABORATORIES (INDIA) LTD is INR ₹ 4.3 Cr.
The registered address of LARK LABORATORIES (INDIA) LTD is A-105/2 OKHLA INDUSTRIAL AREAPHASE II, NEW DELHI, Delhi, India, 110020 - 110020
The CIN number of LARK LABORATORIES (INDIA) LTD is U24230DL1979PLC009548.